• Хайдарова Ф.А., Фахрутдинова С.С
  Республиканский специализированный научно-практический медицинский центр эндокринологии, Республика Узбекистан, г. Ташкент

Аннотация

Наблюдаемое увеличение окружности талии, наряду с увеличением случаев гипертонии и метаболического синдрома у женщин с ПНЯ, может свидетельствовать о предрасположенности к маркерам сердечно-сосудистых заболеваний. 

Калит сузлар

преждевременная недостаточность яичников, сердеч-но-сосудистые заболевания, факторы риска.

Адабиёт

1.    Mozaffarian D, Benjamin EJ, Go AS, Arnett DK, BlahaMJ, Cushman M, etal. Heart disease and stroke statistics-2015 update: a report from the American Heart Association. Circulation. 2015; 131(4):e29- 322.

2.    Benjamin EJ, Blaha MJ, Chiuve SE, Cushman M, Das SR, Deo R, et al. Heart Disease and Stroke Sta­tistics-2017 Update: A Report From the American Heart Association. Circulation. 2017; 135(10):e146- 603.

3.    Vaidya D, Becker DM, Bittner V, Mathias RA, Ouyang P. Ageing, menopause, and ischaemic heart dis­ease mortality in England, Wales, and the United States: modelling study of national mortality data. BMJ. 2011; 343:d5170.

4.    Appiah D, Schreiner PJ, Bower JK, Sternfeld B, Lewis CE, Wellons MF. Is Surgical Menopause Associ­ated With Future Levels of Cardiovascular Risk Factor Independent of Antecedent Levels? The CAR- DIA Study. Am J Epidemiol. 2015; 182(12):991-9.

5.    MukaT, Oliver-Williams C, Kunutsor S, Laven JSE, Fauser BCJM, Chowdhury R, etal. Association of Age at Onset of Menopause and Time Since Onset of Menopause With Cardiovascular Outcomes, Intermediate Vascular Traits, and All-Cause Mortality: A Systematic Review and Meta-analysis. JAMA Cardiol. 2016; 1(7):767-76.

6.    Hong JS, Yi S-W, Kang HC, Jee SH, Kang HG, Bayasgalan G, etal. Age at menopause and cause-spe­cific mortality in South Korean women: Kangwha Cohort Study. Maturitas. 2007; 56(4):411-9.

7.    Wu X, Cai H, Kallianpur A, Li H, Yang G, Gao J, etal. Impact of premature ovarian failure on mortality and morbidity among Chinese women. PLoS One. 2014; 9(3):e89597.

8.    Rocca WA, Grossardt BR, de Andrade M, Malkasian GD, Melton LJ 3rd. Survival patterns after oopho­rectomy in premenopausal women: a population-based cohort study. Lancet Oncol. 2006; 7(10):821-8.

9.    Rocca WA, Gazzuola-Rocca L, Smith CY, Grossardt BR, Faubion SS, Shuster LT, et al. Accelerated Accumulation of Multimorbidity After Bilateral Oophorectomy: A Population-Based Cohort Study. Mayo Clin Proc. 2016; 91(11):1577-89.

10. Webber L, Davies M, Anderson R, Bartlett J, Braat D, Cartwright B, etal. ESHRE Guideline: manage­ment of women with premature ovarian insufficiency. Hum Reprod. 2016; 31(5):926-37.

11. Nelson LM. Clinical practice. Primary ovarian insufficiency. N Engl J Med. 2009; 360(6):606-14.

12. De Vos M, Devroey P, Fauser BCJM. Primary ovarian insufficiency. Lancet (London, England). 2010; 376(9744):911-21.

13. de Almeida DMB, Benetti-Pinto CL, Makuch MY. Sexual function of women with premature ovarian failure. Menopause. 2011; 18(3):262-6.

14. Moreau KL, Hildreth KL, MeditzAL, Deane KD, KoЗГТWM. Endothelial function is impaired across the stages of the menopause transition in healthy women. J Clin Endocrinol Metab. 2012; 97(12):4692- 700.

15. Knauff EAH, Westerveld HE, Goverde AJ, Eikemans MJ, Valkenburg O, van Santbrink EJP, et al. Lipid profile of women with premature ovarian failure. Menopause. 2008; 15(5):919-23.